Tirzepatide: Targets multiple pathways by acting on GLP-1 receptors and additional glucose and energy metabolism mechanisms
This is the predictable result of significant competition and the rise of therapeutic alternatives
The drug will keep you from eating as muchthat is what it is very good at
It provides enough peptide for multiple weeks at lower doses and offers the most flexibility in reconstitution options
55 GLP-1 RAs appear to quiet this internal chatter, potentially by modulating reward pathways in the brain associated with food, making highly palatable foods less enticing and reducing the constant mental preoccupation with eating
Comparable to other peptides linked to fatty acids (e.g., the insulins detemir and degludec, the GLP-1RA liraglutide and semaglutide), the fatty acid side chain allows binding to albumin after subcutaneous injection, slows enzymatic degradation and prolongs biological half-life (5760)